This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Infantile Severe Myoclonic Epilepsy
Information about Infantile Severe Myoclonic Epilepsy: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Infantile Severe Myoclonic Epilepsy
Most recent studies have shown that Infantile Severe Myoclonic Epilepsy shares some biological mechanisms with absence-epilepsy, convulsions, encephalopathies, epilepsies-myoclonic, epilepsies-partial, epilepsy, epilepsy-generalized, febrile-convulsions, impaired-cognition, infantile-spasms, intractable-epilepsy, lennox-gastaut-syndrome, myoclonic-epilepsy-juvenile, myoclonus, partial-seizure, spasm, status-epilepticus, tonic-clonic-epilepsy.
Among the many pathways, these few ones have gauged particular interests from scientists studying Infantile Severe Myoclonic Epilepsy, and have been seen in publications frequently: Aging, Brain Development, Cell Adhesion, Cognition, Drug Resistance, Electron Transport, Electron Transport Chain, Localization, Locomotion, Meiosis, Membrane Depolarization, Myelination, Neuroprotection, Parental Behavior, Pathogenesis, Reflex, Response To Biotin, Spermatogenesis, Translation, Transport
Quite a number of genes have been found to play important roles in Infantile Severe Myoclonic Epilepsy, such as CYP2C19, CYP3A4, DHDDS, DHPS, FST, GABRG2, GBGT1, KCNQ2, KCNQ3, PCDH10, PCDH19, PRPH2, SCN1A, SCN1B, SCN2A, SCN3A, SULT1A1, TRIP10. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.